Skip to content

REducing Stress and Preventing Depression (RESPOND)

A randomised-controlled prevention trial comparing guided and unguided internet-based rumination-focused cognitive-behavioural therapy (i-RFCBT) and a no treatment control to prevent depression in high ruminating young adults

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12683436
Enrollment
237
Registered
2014-10-27
Start date
2013-11-14
Completion date
Unknown
Last updated
2019-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Interventions

i-RFCBT consists of six modules, each taking around an hour to complete in session and 1-to-2 weeks to practise. It includes psycho-education, mood diaries, on-line experiential exercises using audio-
introduction of new technique
practical exercises and planning how to practise or implement the technique in daily life. The key strategies include coaching participants to spot warning signs for rumination and worry, and then to

Sponsors

University of Exeter (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18-24 2. Elevated worry/rumination, defined as scoring above the 75th percentile on at least one of two standard questionnaire measures of worry/rumination 3. Able to understand written English to engage with the intervention 4. Private internet access to ensure confidentiality 5. In line with standard practice, participants currently receiving antidepressant medication will be eligible, provided the dosage has been stable for at least the previous month

Exclusion criteria

Exclusion criteria: 1. Meeting diagnostic criteria for a current (within past month) major depressive episode 2. Current and significant substance abuse or dependence 3. Current symptoms of psychosis or bipolar disorder 4. Current psychological therapy 5. Active suicide risk

Design outcomes

Primary

MeasureTime frame
Onset of a major depressive episode and/or generalized anxiety disorder over a 12-month period, assessed with Structured Clinical Interview for Diagnosis 3 months (post-intervention), 6 months, and 15 months after randomisation.

Secondary

MeasureTime frame
Secondary outcomes will be collected on: 1. Symptoms of depression and anxiety; levels of worry and rumination, measured at baseline, 3, 6, and 15 months post-randomisation 2. Feasibility and acceptability of data collection procedures, levels of attrition, effect size and acceptability of the unguided internet RFCBT intervention.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 3, 2026